North America Injection Pen Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Disposable Injection Pens and Reusable Injection Pens), Therapy (Diabetes, Growth Hormone Therapy, Autoimmune Diseases, Fertility, Cancer, and Others Therapy), and End User (Hospitals and Clinics, Home Care, and Others)

No. of Pages: 130    |    Report Code: BMIRE00028198    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Injection Pen Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Injection Pen Market – by Type

1.3.2        North America Injection Pen Market – by Therapy

1.3.3        North America Injection Pen Market – by End User

1.3.4        North America Injection Pen Market – by Country

2.           North America Injection Pen Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Injection Pen Market – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Expert’s Opinion

5.           North America Injection Pen Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Chronic Disorders

5.1.2        Increase in Strategic Developments

5.2         Market Restraints

5.2.1        Presence of Alternative Drug Delivery Devices and Inadequate Reimbursement Scenario

5.3         Market Opportunities

5.3.1        Increase in Biologics Patent Expiry and Use of Biosimilars

5.4         Future Trends

5.4.1        Technological Advancements and Healthcare Waste Reduction

5.5         Impact Analysis

6.           Injection Pen Market – North America Analysis

6.1         North America Injection Pen Market Revenue Forecast and Analysis

7.           North America Injection Pen Market – Revenue and Forecast to 2028 – by Type

7.1         Overview

7.2         North America Injection Pen Market Revenue Share, by Type 2021 & 2028 (%)

7.3         Disposable Injection Pens

7.3.1        Overview

7.3.2        Disposable Injection Pens: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Reusable Injection Pens

7.4.1        Overview

7.4.2        Reusable Injection Pens: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

8.           North America Injection Pen Market Analysis and Forecast to 2028 – by Therapy

8.1         Overview

8.2         North America Injection Pen Market, by Therapy 2021 & 2028 (%)

8.3         Diabetes Therapy

8.3.1        Overview

8.3.2        Diabetes Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Growth Hormone Therapy

8.4.1        Overview

8.4.2        Growth Hormone Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Autoimmune Diseases Therapy

8.5.1        Overview

8.5.2        Autoimmune Diseases Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Fertility Therapy

8.6.1        Overview

8.6.2        Fertility Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

8.7         Cancer Therapy

8.7.1        Overview

8.7.2        Cancer Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

8.8         Other Therapies

8.8.1        Overview

8.8.2        Other Therapies: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

9.           North America Injection Pen Market – Revenue and Forecast to 2028 – by End User

9.1         Overview

9.2         North America Injection Pen Market Revenue Share, by End User 2021 & 2028 (%)

9.3         Home Care

9.3.1        Overview

9.3.2        Home Care: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Hospitals & Clinics

9.4.1        Overview

9.4.2        Hospitals & Clinics: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Others

9.5.1        Overview

9.5.2        Others: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

10.        North America Injection Pen Market – Revenue and Forecast to 2028 – Country Analysis

10.1      Overview

10.1.1     North America: Injection Pen Market, by Country, 2021 & 2028 (%)

10.1.1.1       US: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       US: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3       US: Injection Pen Market, by Type, 2019–2028 (US$ Million)

10.1.1.1.4       US: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)

10.1.1.1.5       US: Injection Pen Market, by End User, 2019–2028 (US$ Million)

10.1.1.2       Canada: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       Canada: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3       Canada: Injection Pen Market, by Type, 2019–2028 (US$ Million)

10.1.1.2.4       Canada: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)

10.1.1.2.5       Canada: Injection Pen Market, by End User, 2019–2028 (US$ Million)

10.1.1.3       Mexico: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       Mexico: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       Mexico: Injection Pen Market, by Type, 2019–2028 (US$ Million)

10.1.1.3.4       Mexico: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)

10.1.1.3.5       Mexico: Injection Pen Market, by End User, 2019–2028 (US$ Million)

11.        North America Injection Pen Market – Industry Landscape

11.1      Overview

11.2      Inorganic Growth Strategies

11.2.1     Overview

11.3      Organic Growth Strategies

11.3.1     Overview

12.        Company Profiles

12.1      Eli Lilly and Co

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Novo Nordisk AS

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Owen Mumford Ltd

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Sanofi SA

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Merck KGaA

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Haselmeier GmbH

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Gerresheimer AG

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Becton Dickinson and Co

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      AstraZeneca Plc

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Teva Pharmaceutical Industries Ltd

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)

Table 4.             US Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Canada Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Canada Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Canada Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Mexico Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Mexico Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Mexico Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Recent Inorganic Growth Strategies in the Injection Pen Market

Table 12.          Recent Organic Growth Strategies in the Injection Pen Market

Table 13.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Injection Pen Market Segmentation

Figure 2.           North America Injection Pen Market, by Country

Figure 3.           North America Injection Pen Market Overview

Figure 4.           North America Injection Pen Market, by Type

Figure 5.           North America Injection Pen Market, by Country

Figure 6.           North America: PEST Analysis

Figure 7.           Experts’ Opinion

Figure 8.           North America Injection Pen Market: Impact Analysis of Drivers and Restraints

Figure 9.           North America Injection Pen Market – Revenue Forecast and Analysis – 2020–2028

Figure 10.        North America Injection Pen Market Revenue Share, by Type 2021 & 2028 (%)

Figure 11.        Disposable Injection Pens: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Reusable Injection Pens: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        North America Injection Pen Market, by Therapy 2021 & 2028 (%)

Figure 14.        Diabetes Therapy: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Growth Hormone Therapy: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Autoimmune Diseases Therapy: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Fertility Therapy: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Cancer Therapy: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Other Therapies: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        North America Injection Pen Market Revenue Share, by End User 2021 & 2028 (%)

Figure 21.        Home Care: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Hospitals & Clinics: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Others: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        North America: Injection Pen Market, by Key Country – Revenue (2022) (US$ Million)

Figure 25.        US: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Canada: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Mexico: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million) 

The List of Companies - North America Injection Pen Market

  1. AstraZeneca Plc
  2. Becton Dickinson and Co
  3. Eli Lilly and Co
  4. Gerresheimer AG
  5. Haselmeier GmbH
  6. Merck KGaA
  7. Novo Nordisk AS
  8. Owen Mumford Ltd
  9. Sanofi SA
  10. Teva Pharmaceutical Industries Ltd